Saturday, July 11, 2026

Drug profile · INN

trientine dihydrochloride

trientine dihydrochloride (CUFENCE) is a copper chelating agent.

EMA: approved Alimentary tract and metabolism (A16) A16A
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — trientine dihydrochloride
Class
Alimentary tract and metabolism (A16)
Route
Patents
0
Programs
1
Data quality
0.83

Quick answer

trientine dihydrochloride (CUFENCE) is a copper chelating agent.

Key facts

INN trientine dihydrochloride
Brand CUFENCE
Mechanism Copper chelating agent
Target Copper
Therapeutic class Alimentary tract and metabolism (A16)
ATC code A16A

Mechanism of action

Copper chelating agent

Primary target: Copper

Approval history

Authority Status Date
EMA approved

Pipeline programs

  1. Cufence 200 mg hard capsules Approved · Univar Solutions · Wilson’s Disease

Related & competitor drugs

  1. agalsidase alfa Alimentary tract and metabolism (A16)
  2. alogliptin Alimentary tract and metabolism (A10)
  3. alogliptin benzoate Alimentary tract and metabolism (A10)
  4. aprepitant Alimentary tract and metabolism (A04)
  5. budesonide Alimentary tract and metabolism (A07)
  6. canagliflozin Alimentary tract and metabolism (A10)

Frequently asked questions

What is trientine dihydrochloride?

trientine dihydrochloride (CUFENCE) is a copper chelating agent.

What is the brand name for trientine dihydrochloride?

CUFENCE is a marketed brand name for trientine dihydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.